Tom Edward Pike

Neomed Management AS is an investment firm based in Oslo. Founded in 1998, the firm specializes in private equity investments in the healthcare and life science sectors. Neomed advises several funds namely NeoMed I, II, III, IV and V.

Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway.

ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden.

Legemiddelindustrien provides pharmaceutical industry services. The private company is based in Oslo, Norway.

Acd Pharmaceuticals AS is a Norwegian biotechnology company that focuses on research and development. The private company is based in Oslo, Norway.

Europharma Apotek AS is a private company based in Oslo, Norway.

Vectron Biosolutions AS is a Norwegian company that specializes in developing protein production processes for researchers and manufacturers. The company is based in Trondheim, NO. The company's mission is to support their customers in realizing higher success rates, greater yields, and reduced cost of goods. The company offers tailor-made solutions by leveraging their proprietary expression technologies and extensive experience. and has subsidiaries in the United States. The company was founded in 2008, and Trond Erik Vee Aune has been the CEO of the company since 2008.

Kaydence Pharma AS engages in the manufacturing of pharmaceutical raw materials. The company was founded on October 27, 2017 and is headquartered in Oslo, Norway.

Kaydence Pharma USA operates as a pharmaceutical company. It offers vitamins, dietary supplement, and therapy to help patients prevent and reverse vascular diseases. The company is headquartered in East Brunswick, NJ.